CRTP Alumni

Since inception in 2009, BHCRI has awarded over $6.9M in stipend support to 207 graduate students, postdoctoral fellows, and medical residents pursuing cancer research careers within Atlantic Canada. CRTP provides trainees with opportunities to develop leadership skills, gain an appreciation of decision making processes such as peer review and contribute to the overall operation of BHCRI.  The skills learned through CRTP provide the building blocks for success, regardless of career direction.

Some of our alumni:

January 2023:

 

Sabateeshan Mathavarajah

Supervisor: Dr. Graham Dellaire

Project Title: The role of the PML gene in protecting our genetic material and preventing development of cancer

CRTP Term: January 2023 – December 2023

 

 

Mika Park

Supervisor: Dr. Graham Dellaire

Project Title: Investigating the role of promyelocytic leukemia protein in lung cancer cell migration and tumour formation

CRTP Term: January 2023 – August 2023

Aditya Vardhan

Supervisor: Dr. Amitabh Jha

Project Title: Design, Synthesis and Bioevaluation of Novel Curcumin Analogs

CRTP Term: January 2023 – August 2023

September 2022:

Dharmapal Burne

Supervisor: Dr. Daniel Gaston

Project Title: Bioinformatic analysis of clinically oriented molecular genomics testing in Lung Cancer

CRTP Term: September 2022 – August 2023

Stefan Heinze-Milne

Supervisor: Dr. Scott A. Grandy

Project Title: The impact of prehabiliation exercise on frailty and treatment outcomes in people diagnosed with ovarian cancer

CRTP Term: September 2022 – August 2023

Rachel Lee

Supervisor: Dr. Sheila N. Garland

Project Title: Exploring Canadian Cancer Survivors’ use of Cannabis as a Sleep Aid

CRTP Term: September 2022 – August 2023

Lia Massoeurs

Supervisor: Dr. Gabriela Ilie

Project Title: A Realist Evaluation of the heterogeneity in mental health outcomes in a sample of participants in the Prostate Cancer Patient Empowerment Program (PC-PEP Phase 3 Randomized Clinical Trial)

CRTP Term: September 2022 – August 2023

Roopa Nanjundappa

Supervisor: Dr. Jean Marshall

Project Title: Understanding mast cell response to oncolytic virus

CRTP Term: September 2022 – August 2023

Miranda Steeves

Supervisor: Dr. Marya Ahmed

Project Title: Development of Target Delivery Carriers for Breast Cancer Treatment

CRTP Term: September 2022 – August 2023

January 2022:

Farideh Badichi Akher

Supervisor: Dr. Jan Rainey

Project Title: Engineering of recombinant spider silk-based fusion proteins with specific functionality to sequester target bioactive proteins

CRTP Term: January 2022 - September 2022

Elias Bashir Habib

Supervisor: Dr. Graham Dellaire

Project Title: Activation of Pro-Survival Signaling Pathways in Breast and Cervical Cancer Cells Occurs in Response to Loss of Pre-mRNA Processing Factor 4 Kinase

CRTP Term: January 2022 – August 2023

Jae Ho Han

Supervisor: Dr. Adrienne Weeks

Co-supervisor: Dr. Jeremy Roy

Project Title: Modelling extracellular vesicles in patient plasma and organotypic-derived cultures for predicting recurrence or progression of astrocytomas

CRTP Term: July 2022 – June 2023

Naeimeh Jafari

Supervisor: Dr. Brendan Leung

Project Title: The oral microbiome impact on chemotherapy-induced oral mucositis (CIOM)

CRTP Term: January 2022 – December 2022

Michaela Kember

Supervisor: Dr. Zhenyu Cheng

Project Title: Characterization of the Effects of RACK1 Expression on Mitochondrial Physiology

CRTP Term: January 2022 –  August 2023

Stephanie Kendall

Supervisor: Dr. Scott A. Grandy

Project Title: Using metabolomics to analyze the effects of aerobic exercise on anthracycline-induced cardiotoxicity in breast cancer patients

CRTP Term: January 2022 – August 2023

Samlau Kutana

Supervisor: Dr. Sheila N. Garland

Project Title: User-centered development and testing of a smartphone app to treat insomnia in cancer survivors

CRTP Term: January 2022 – August 2023

Rhea Nickerson

Supervisor: Dr. Brent Johnston

Project Title: The Role of the Chemokine Receptor CXCR3 Axis in the Efficacy of Oncolytic Vesicular Stomatitis Virus Therapy in Combination with Natural Killer T Cell Activation Immunotherapy in Melanoma

CRTP Term: January 2022 – August 2022

Patrick Pearson

Supervisor: Dr. Thomas Belbin

Project Title: Characterizing the tumour suppressive properties of Krüppel type zinc finger gene ZNF154 in head and neck cancer

CRTP Term:  January 2022 - August 2022

Olivier Philips

Supervisor: Dr. J. Patrick Murphy

Project Title: Investigation of functional metabolites produced by the serine biosynthesis pathway in triple negative breast cancers

CRTP Term: January 2022 – August 2023

September 2021:

 

Jaganathan Venkatesh

Supervisor: Dr. Paola Marcato

Project Title: LINC01929 is a novel mediator of breast cancer progression and tumour immune suppression

CRTP Term – September 2021 – December 2023

 

 

Mohsen Aziz Pouri Aghdam

Supervisor: Dr. Scott A. Grandy

Project Title: Investigating the neurophysiological outcomes of Postoperative Resistance Exercise Intervention for Patients following Grade II and III Astrocytoma treatment: A Quasi-randomised Trial

CRTP Term: September 2021 – August 2023

Zara Forbrigger

Supervisor: Dr. Andrew Stadnyk

Co-supervisor: Dr. Ketan Kulkarni

Project Title: Can the characterization of post-induction treatment ALL cells be used to predict pegaspargase treatment failure?”

CRTP Term: September 2021 – August 2023

William Johnston

Supervisor: Dr. Scott A. Grandy

Project Title: EXercise to prevent AnthrCycline-based Cardio-Toxicity (EXACT 2.0) in individuals with breast cancer

CRTP Term: September 2021 - August 2022

Julia Kaal

Supervisor: Dr. Robin Urquhart

Project Title: An evidence-based, practice-oriented approach to transition young adult cancer survivors to community based survivorship care in Nova Scotia (NS): including and optimizing the role of primary care

CRTP Term: September 2021 – August 2023

Olaide Abosede Laoye

Supervisor: Dr. Scott A. Grandy

Project Title: The Mediating Role of Exercise on the Relationship between Sleep Quality and Cancer-Related Fatigue in Cancer Survivors

CRTP Term: September 2021 – August 2023

Dongpu Li

Supervisor: Dr. Jun Wang

Project Title: Exploring the role of IL-17RA in the development of cancer stem cells

CRTP Term: September 2021 – August 2023

Brendan McKeown

Supervisor: Dr. Kerry B. Goralski

Project Title: Jadomycin B Mechanism of Action and Anti-Metastatic Effects in Triple-Negative, Multi-Drug Resistant Breast Cancer

CRTP Term: September 2021 – August 2023

Phoebe Phonchareon

Supervisor: Dr. Jean Marshall

Project Title: Investigation of IL-5 Enhanced Production of Type I Interferons by Mast Cells

CRTP Term: September 2021 – August 2023

Rahimeh Rasouli

Supervisor: Dr. Marya Ahmed

Project Title: Dual siRNA loaded nanoparticles for Breast Cancer Treatment

CRTP Term: September 2021 – August 2023

Margaret Sheridan

Supervisor: Dr. Ravi Ramjeesingh

Project Title: Colorectal and Hepatobiliary Cancer in Nova Scotia: Where We Are and Where We Are Going

CRTP Term: September 2021 – August 2023

Jillian Vallis

Supervisor: Dr. Peizhong Peter Wang

Co-supervisor: Dr. Alex Mathieson

Project Title: Effects of genetic biomarkers on clinical outcomes in colorectal cancer in the Newfoundland and Labrador population

CRTP Term: September 2021 – August 2023

Jessica Vickery

Supervisor: Dr. Robin Urquhart

Project Title: Investigating How the Type and Magnitude of Needs Post-Treatment Impact Health Care Utilization in Cancer Survivors

CRTP Term: September 2021 - August 2023

Sajeev Wagle

Supervisor: Dr. H.P. Vasantha Rupasinghe

Project Title: Anti cancer effect of natural products in Dogs. This project involves screening of natural products in human and canine osteosarcoma and find suitable mode of action of natural extracts

CRTP Term: September 2021 – August 2023

January 2021:

Nick Dawe

Supervisor: Dr. Brenden Leung

Project Title: Fabrication and validation of a sandwiched spheroid platform to preserve tumour heterogeneity for in vitro drug screening

CRTP Term: January 2021 – August 2022

Smitha George

Supervisor: Dr. Francesca Di Cara

Project Title: Defining conserved metabolic networks that promote abnormal growth and division in tumorigenesis using the genetic model system Drosophila melanogaster

CRTP Term: January 2021 – December 2021

Vishnupriyan Kumar

Supervisor: Dr. Shashi Gujar

Project Title: HLA ligandomics of Pulmonary-Only metastatic Prostate Cancer (PO-mPCa): Implications for precision medicine

CRTP Term: January 2021 – December 2022

Modeline Longjohn

Supervisor: Dr. Sherri L. Christian

Project Title: Monitoring of pediatric B cell acute lymphoblastic leukemia (B-ALL) disease progression: an extracellular vesicle-based approach

CRTP Term: January 2021 – December 2022

Kateryna Kratzer

Supervisor: Dr. Graham Dellaire

Project Title: Exploring the relationship between homologous recombination and chemotherapy sensitivity

CRTP Term: January 2021 – December 2022

Danick Martin

Supervisor: Dr. Gilles Robichaud

Project Title: Functional Characterization of Pax-5 circular RNA in B Lymphocytes Malignancies

CRTP Term: January 2021 – December 2022

Sina Mazinani

Supervisor: Dr. Kirill Rosen

Project Title: PPAR gamma antagonists as tools for blocking progression of ErbB2-positive trastuzumab-resistant breast cancer

CRTP Term: January 2021 – December 2021

Nikitha Kendyala, CEO/Co-Founder
Nucliq Biologics Inc.

CRTP Trainee 2015 — 2016

I am originally from Hyderabad, India where I started my science career with a bachelor’s major in Biotechnology, Bioinformatics and Chemistry and little did I know back then that I would be part of starting a biotechnology company largely based on bioinformatics analysis. My research career started with my Master’s thesis on therapeutic vaccine development for cervical cancer. This work experience and learnings encouraged me to pursue my Ph. D. in cancer research. I moved to Canada to pursue my Ph.D. with Dr. Sherri Christian at Memorial. During my Ph.D. I worked on two projects and was supported by CRTP for the Development of 3D co-culture system to study the epithelial and mesenchymal transition of breast cancer cells in presence of adipocytes. Being a CRTP trainee was a great opportunity to get the exposure to other research and researchers and understand the progress of the outside world relative to your lab research. The interactions during the conferences, seminar series and presentations helped me to assess my work and presentation abilities. I could also use the skill training program and develop a novel 3D co-culture methods to study the cells in 3D microenvironment at University of Guelph, Guelph. In addition, I had exposure to different lab culture and people from different backgrounds whom I still in contact with. Apart from scientific knowledge enhancement, networking and interacting through various opportunities provided by CRTP allowed me to understand and apply the cultures that involves the inclusion and diversity in our company, Nucliq Biologics Inc. I am thankful to Beatrice Hunter Cancer Research Institute for providing the opportunity which helped me learn and understand various aspects of my research world.